eFFECTOR Therapeutics (EFTR) Short Interest Ratio & Short Volume $0.0002 0.00 (0.00%) As of 12:12 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock eFFECTOR Therapeutics Short Interest DataeFFECTOR Therapeutics (EFTR) has a short interest of 5,700 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 1.2, indicating that it would take 1.2 days of the average trading volume of 3,063 shares to cover all short positions.Current Short Interest5,700 sharesPrevious Short Interest5,700 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$1.14Short Interest Ratio1.2 Days to CoverLast Record DateAugust 15, 2025Outstanding Shares4,704,000 sharesPercentage of Shares Shorted0.12%Today's Trading Volume200 sharesAverage Trading Volume3,063 sharesToday's Volume Vs. Average7% Short Selling eFFECTOR Therapeutics? Sign up to receive the latest short interest report for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEFTR Short Interest Over TimeEFTR Days to Cover Over TimeEFTR Percentage of Float Shorted Over Time eFFECTOR Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/20255,700 shares $1.14 No ChangeN/A1.2 $0.00 7/31/20255,700 shares $1.14 No Change0.1%3.6 $0.00 7/15/20255,700 shares $1.14 No ChangeN/A4.1 $0.00 6/30/20255,700 shares $1.71 No Change0.1%5.2 $0.00 6/15/20255,700 shares $1.71 No Change0.1%0.8 $0.00 5/31/20255,700 shares $0.00 No Change0.1%0.7 $0.00 5/15/20255,700 shares $3.42 No ChangeN/A2.6 $0.00 4/30/20255,700 shares $1.14 No ChangeN/A1.1 $0.00 4/15/20255,700 shares $1.14 No ChangeN/A9.5 $0.00 3/14/20255,700 shares $3.42 No ChangeN/A3.8 $0.00 Get the Latest News and Ratings for EFTR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/28/20255,700 shares $1.14 No ChangeN/A9.5 $0.00 2/14/20255,700 shares $1.14 No ChangeN/A9.5 $0.00 1/31/20255,700 shares $1.14 No ChangeN/A1.1 $0.00 1/15/20255,700 shares $1.14 No ChangeN/A2.7 $0.00 6/30/2024687,000 shares $199.30 thousand +650.0%16.8%1.1 $0.29 6/15/202491,600 shares $114.50 thousand -3.3%2.3%0.1 $1.25 5/31/202494,700 shares $151.52 thousand -14.5%2.4%0.3 $1.60 5/15/2024110,700 shares $219.19 thousand -13.7%2.9%0.3 $1.98 4/30/2024128,300 shares $288.68 thousand -47.4%3.1%0.3 $2.25 4/15/2024244,000 shares $470.92 thousand -29.3%7.2%0.7 $1.93 3/31/2024345,200 shares $4.97 million +8.5%10.7%1 $14.39 3/15/2024318,100 shares $3.52 million +43.1%15.0%2.2 $11.06 2/29/2024222,300 shares $3.21 million +113.8%10.5%1.6 $14.44 2/15/2024104,000 shares $1.21 million -4.4%4.9%0.9 $11.66 1/31/2024108,800 shares $1.25 million -12.6%5.9%1 $11.47 1/15/2024124,500 shares $1.33 million -85.0%6.7%1.3 $10.69 12/31/2023827,900 shares $386.96 thousand -21.9%1.8%0.4 $0.47 12/15/20231,060,000 shares $398.35 thousand +1.0%2.3%0.6 $0.38 11/30/20231,050,000 shares $556.92 thousand +141.9%2.3%0.8 $0.53 11/15/2023434,000 shares $253.89 thousand +72.8%1.0%0.6 $0.59 10/31/2023251,100 shares $135.59 thousand -50.5%0.7%0.6 $0.54 10/15/2023507,600 shares $291.06 thousand +133.9%1.3%1.1 $0.57 9/30/2023217,000 shares $130.18 thousand -74.0%0.6%0.5 $0.60 9/15/2023834,100 shares $508.80 thousand -8.5%2.2%1.4 $0.61 8/31/2023912,000 shares $663.94 thousand +36.7%2.4%1 $0.73 8/15/2023667,400 shares $453.23 thousand -38.8%1.7%0.3 $0.68 7/31/20231,090,000 shares $881.16 thousand -15.5%3.6%0.5 $0.81 7/15/20231,290,000 shares $990.72 thousand +219.3%4.2%0.6 $0.77 6/30/2023404,000 shares $335.40 thousand +91.4%1.4%0.2 $0.83 6/15/2023211,100 shares $197.38 thousand -83.0%0.8%0.1 $0.94 5/31/20231,240,000 shares $1.15 million +1,506.2%4.6%0.8 $0.93 5/15/202377,200 shares $52.87 thousand -12.6%0.4%0.4 $0.68 4/30/202388,300 shares $41.50 thousand -32.5%0.6%0.5 $0.47 4/15/2023130,800 shares $50.36 thousand +236.3%0.7%0.7 $0.39 3/31/202338,900 shares $13.72 thousand -45.2%0.1%0.2 $0.35 3/15/202371,000 shares $28.40 thousand +110.7%0.2%0.2 $0.40 2/28/202333,700 shares $16.79 thousand -72.2%0.3%0.1 $0.50 2/15/2023121,300 shares $72.78 thousand -9.1%0.9%0.4 $0.60 1/31/2023133,400 shares $68.45 thousand -29.3%1.0%0.4 $0.51 1/15/2023188,800 shares $84.96 thousand +56.4%1.4%0.7 $0.45 12/30/2022120,700 shares $51.61 thousand +148.9%0.9%0.5 $0.43 12/15/202248,500 shares $19.40 thousand +41.4%0.4%0.5 $0.40 11/30/202234,300 shares $14.40 thousand -49.9%0.3%0.3 $0.42 11/15/202268,400 shares $37.70 thousand -51.7%0.5%0.5 $0.55 10/31/2022141,600 shares $86.76 thousand +13.2%1.1%0.1 $0.61 10/15/2022125,100 shares $73.30 thousand -42.5%1.0%0.1 $0.59 9/30/2022217,500 shares $124.43 thousand +55.0%1.7%0.2 $0.57 9/15/2022140,300 shares $83.07 thousand -25.5%1.1%0.1 $0.59 8/31/2022188,300 shares $114.77 thousand +21.5%1.4%0.2 $0.61 8/15/2022155,000 shares $111.03 thousand +104.8%1.3%0.1 $0.72 7/31/202275,700 shares $61.30 thousand -19.5%1.0%0.1 $0.81 7/15/202294,000 shares $105.28 thousand -30.4%1.2%1.5 $1.12 6/30/2022135,000 shares $191.70 thousand -12.0%1.8%3.1 $1.42 6/15/2022153,400 shares $225.50 thousand -13.2%2.0%4 $1.47 5/31/2022176,700 shares $381.67 thousand +0.8%2.3%5.2 $2.16 5/15/2022175,300 shares $315.54 thousand -26.2%2.3%6.7 $1.80 4/30/2022237,400 shares $790.54 thousand -1.7%3.2%8.1 $3.33 4/15/2022241,600 shares $850.43 thousand -3.4%3.2%7.9 $3.52 3/31/2022250,000 shares $1.00 million -6.6%N/A7.7 $4.01 3/15/2022267,700 shares $1.07 million -11.7%3.8%4.5 $4.00 2/28/2022303,100 shares $1.41 million -6.2%4.6%3.2 $4.65 2/15/2022323,200 shares $1.49 million -2.4%N/A3 $4.61 1/31/2022331,300 shares $1.87 million -5.3%5.1%2.7 $5.65 1/15/2022350,000 shares $2.54 million -5.9%N/A2.7 $7.25 12/31/2021372,100 shares $3.08 million No Change5.0%1.9 $8.28 EFTR Short Interest - Frequently Asked Questions What is eFFECTOR Therapeutics' current short interest? Short interest is the volume of eFFECTOR Therapeutics shares that have been sold short but have not yet been closed out or covered. As of August 15th, investors have sold 5,700 shares of EFTR short. Learn More on eFFECTOR Therapeutics' current short interest. What is a good short interest ratio for eFFECTOR Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EFTR shares currently have a short interest ratio of 1.0. Learn More on eFFECTOR Therapeutics's short interest ratio. How does eFFECTOR Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to eFFECTOR Therapeutics: Ampio Pharmaceuticals, Inc. (0.01%), PaxMedica, Inc. (0.01%), Calithera Biosciences, Inc. (0.14%), Clever Leaves Holdings Inc. (0.48%), OncoSec Medical Incorporated (0.00%), CytoMed Therapeutics Limited (0.86%), Eloxx Pharmaceuticals, Inc. (0.07%), Galapagos NV (3.42%), Minerva Neurosciences, Inc (0.62%), NexImmune, Inc. (0.27%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Lucid Group, Inc. ($8.00 billion), Spotify Technology ($5.48 billion), AppLovin Corporation ($5.11 billion), Reddit Inc. ($5.02 billion), Coinbase Global, Inc. ($3.99 billion), Charter Communications, Inc. ($3.89 billion), Live Nation Entertainment, Inc. ($3.18 billion), Seagate Technology Holdings PLC ($2.59 billion), ResMed Inc. ($2.55 billion), and Rocket Lab Corporation ($2.52 billion). View all of the most shorted stocks. What does it mean to sell short eFFECTOR Therapeutics stock? Short selling EFTR is an investing strategy that aims to generate trading profit from eFFECTOR Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against eFFECTOR Therapeutics? A short squeeze for eFFECTOR Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EFTR, which in turn drives the price of the stock up even further. How often is eFFECTOR Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EFTR, twice per month. The most recent reporting period available is August, 15 2025. More Short Interest Resources from MarketBeat Related Companies AMPE Short Interest Data PXMD Short Interest Data CALA Short Interest Data CLVR Short Interest Data ONCSQ Short Interest Data ALVOW Short Interest Data BCTXW Short Interest Data CLVRW Short Interest Data CMRAW Short Interest Data GDTC Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EFTR) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersMusk Warns. Trump Acts. Your Retirement May Depend on ItWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding eFFECTOR Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share eFFECTOR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EFTR Stock Alerts